(Q33222370)

24 July 2017

title

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial (English)

1 reference

24 July 2017

0 references

Plasmodium falciparum

0 references

artesunate

0 references

randomized experiment

1 reference

2

François Nosten

1 reference

24 July 2017

3

Kasia Stepniewska

1 reference

24 July 2017

Arjen Dondorp

1

1 reference

24 July 2017

Nick Day

series ordinal

4

1 reference

24 July 2017

Nick White

series ordinal

5

1 reference

24 July 2017

South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group

series ordinal

6

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

24 July 2017

2005

1 reference

1 reference

24 July 2017

unknown value

object named as

The Lancet

1 reference

COCI

volume

366

2 references

24 July 2017

9487

2 references

24 July 2017

717-725

2 references

Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand

24 July 2017

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Treatment of falciparum malaria caused by strain resistant to quinine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Role of quinine in the high mortality of intramuscular injection tetanus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Severe Hypoglycemia and Hyperinsulinemia in Falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Abnormal blood flow and red blood cell deformability in severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Estimating sequestered parasite population dynamics in cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Central role of the spleen in malaria parasite clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Optimal regimens of parenteral quinine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

A trial of artemether or quinine in children with cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

Severe allergic reactions to oral artesunate: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967176-0

7 January 2021

10.1016/S0140-6736(05)67176-0

Identifiers

DOI

2 references

24 July 2017

1 reference